DECISION NO. 89 of April 25th 2024
of the Ordinary General Meeting of Shareholders
Farmaceutica REMEDIA S.A.
J20/700/1991, CUI RO 2115198
Adopted today, 25.04.2024 at the secondary headquarters of the company from BUCHAREST, B-dul Metalurgiei no. 78, sector 4.
Following the debate of the items on the agenda, the Ordinary General Meeting of Shareholders decides, with the vote of the shareholders present and represented holding a number of 78.543.467 voting shares, representing 82,9759% of the total number of voting shares in the share capital of Farmaceutica REMEDIA SA (total voting shares 94.658.195 representing 99,1384% of the share capital of Farmaceutica REMEDIA S.A.), the following:
Art. 1. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
Election, based on Article 129 of Law 31/1990 on companies, republished, of the secretariat of the Ordinary General Meeting of Shareholders, consisting of secretary - Florin Dan CADIA, shareholder of the company.
Art. 2. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
Approval of the audited, consolidated and unconsolidated financial statements for 2023, based on the reports submitted by the President of the Board of Administrators and by the financial auditor, having the following representative
data:
Indicator | Values registered | Values registered |
on December 31th | on December 31th | |
2023 (LEI) | 2023 (LEI) | |
unconsolidated | consolidated | |
Net turnover | 15.379.933 | 593.358.927 |
Operating revenues - TOTAL | 20.953.750 | 598.280.230 |
Operating costs - TOTAL | 21.936.274 | 590.124.539 |
Financial revenues - TOTAL | 5.413.254 | 1.298.237 |
Financial costs - TOTAL | 55.867 | 545.353 |
TOTAL REVENUES | 26.367.003 | 599.578.467 |
TOTAL COSTS | 21.992.142 | 590.669.892 |
Tax | - | 1.706.927 |
NET PROFIT | 4.374.862 | 7.201.648 |
Non-current assets- TOTAL | 49.600.693 | 46.768.058 |
Current assets - TOTAL | 15.001.185 | 268.433.018 |
TOTAL ASSETS | 64.973.864 | 315.761.523 |
Equity | 52.856.662 | 70.859.551 |
TOTAL long-term liabilities | 4.894.215 | 5.447.865 |
TOTAL short-term liabilities | 7.222.987 | 239.454.107 |
TOTAL EQUITY AND LIABILITIES | 64.973.863 | 315.761.523 |
Art.3. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
Approval of the discharge from administration of administrators for the financial year 2023.
Art. 4. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
Approval of the budget of income and expenditures for 2024, unconsolidated and consolidated, having the following representative data:
Indicator | Value (LEI) | Value (LEI) |
unconsolidated | consolidated | |
TOTAL REVENUES, from which: | 682.852.000 | 31.480.000 |
Net revenues from sale of merchandise | 671.142.000 | 18.100.000 |
Other revenues | 10.640.000 | 7.030.000 |
Financial revenues | 1.070.000 | 6.350.000 |
Provisions revenues | 670.004.169 | 25.393.230 |
TOTAL COSTS, from which: | 619.987.439 | 12.070.000 |
Net cost of sold merchandise | 44.447.730 | 9.223.230 |
Other costs | 5.569.000 | 4.100.000 |
Amortization & provisions | 12.847.831 | 6.086.770 |
GROSS PROFIT | 682.852.000 | 31.480.000 |
Art.5. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
Approval of the activity and investment program for 2024 having the proposed investment value of LEI 14.195.500 for Farmaceutica REMEDIA SA and for Farmaceutica REMEDIA Distribution & Logistics S.R.L.
Art.6. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
Approval of the Board of Administrators proposal of destination distribution of the net profit achieved in fiscal year 2023, as follows:
DESTINATION | AMOUNT (Lei) |
Dividends from the profit for 2023 | 4.374.862 |
Dividends from the other reserves | 358.214 |
Total dividends | 4.733.076 |
Undistributed profit | 0 |
TOTAL DISTRIBUTED NET PROFIT 2023 | 4.374.862 |
Art.7. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
- Setting the gross dividend per share at LEI 0,05;
- Approval of the date of 30.09.2024 as the payment date - in compliance with the provisions of Art. 87 (2) of Law No. 24/2017 and Art. 178 (2) from the F.S.A. Regulation No. 5/2018;
- Approval of the deadline for keeping available to shareholders the dividends 3 (three) years from the payment date;
- Empowerment of the Board of Administrators to choose the payment agent and to establish the dividends distribution procedure, in compliance with the legal provisions in force.
-
Approval for bearing the costs of dividends distribution by Farmaceutica REMEDIA
S.A.
Art.8. With a total of 78.543.467 votes expressed, representing 82,9759% of the share capital, the AGM, by secret ballot, the AGM elect the Board of Administrators of Farmaceutica REMEDIA S.A. consisting of 3 (three) administrators with a mandate of 1 (one) year respectively from 01.05.2024 to 30.04.2025, with the following compositions:
- President of the Board of Administrators, TARUS" - Valentin Norbert TARUS e.U. legal person registered in Austria, Handelsgericht Wien - FN 349134 represented by Mr Valentin-NorbertTARUS, Austrian citizen, residing in Vienna, Austria, with full powers of administration and representation;
- Member of the Board of Administrators, Cristian PLOCON, Romanian citizen, residence in Bucharest, Romania, with full powers of administration and representation;
- Member of the Board of Administrators, Lucian Valentin CODREANU, Romanian citizen, residence in Cristian, Romania, with full powers of administration and representation;
The mandate of the former Board of Administrators ends on 30.04.2024.
Art.9. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
- Approval of The Remuneration Report for 2023 of the management of the society Farmaceutica REMEDIA S.A.;
- The remuneration for the members of the Board of Administrators, the General Director, Administrators, as well as for the Directors with mandate contract, and the maximum limit for the additional remunerations and other benefits that can be granted out of the unconsolidated net profit, all these for the period 01.05.2024 - 30.04.2025, as follows:
- the remuneration of the Board of Administrators, General Director, Administrators and the Directors with mandate contract is limited to maximum RON 200.000 net per month;
- the annual bonus for the members of the Board of Administrators, General Director, Administrators and the Directors with mandate contract, based on the Board of Administrators approval, is limited to maximum 15 % of the net profit, according to the mandate contracts, after the approval of the annual financial reports (all taxes included).
- Mandating the Board of Administrators to establish, based on the performances realised, the distribution of benefits for the members of the Board of Administrators, the General Director, as well as for the Directors with mandate contract.
Art.10. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides, elect the external financial auditor PREMIER CLASS AUDIT SRL, J12/2994/2013, CUI 32310697, represented by Cobîrzan Sergiu Bogdan for the period from 01.05.2024 to 30.04.2025.
Art.11. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
Approval of empowering the Board of Administrators to explore and identify opportunities and negotiate with eligible entities, natural or legal persons, in the following directions:
- acquisition of shares and/or equity issued by third parties;
- entering into partnerships for the development of new business directions, including through the establishment of new legal entities in which Farmaceutica REMEDIA S.A. is a partner;
- identification of investors for the acquisition of goodwill related to all or parts of the total number of the company's working points (pharmacies) and negotiation of contractual terms and conditions with the identified investors.
- finding opportunities for the consolidation of the distribution and logistics activities of Farmaceutica REMEDIA Distribution & Logistics S.R.L.;
- hiring specialized evaluators to carry out the operations referred to in items a), b), c), d).
- empowering the Board of Administrators to approve projects and substantiated proposals for the above directions to be submitted to the A.G.E.A. for approval.
Art.12. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
Approval of the date of 12.09.2024 as the registration date, in compliance with the provisions of Art. 87 (1) of Law No. 24/2017.
Art.13. With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
Approval of the date of 11.09.2024 as ex-date, in compliance with the provisions of Art. 176
- from the FSA Regulation No. 5/2018 and Art. 2 (2) letter l from the FSA Regulation No. 5/2018.
Art.14 With a total of 78.543.467 votes expressed, representing 82,9759 % of the share capital, of which 78.543.467 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:
Empowerment of Mr Valentin-Norbert TARUS representing "TARUS" - Valentin Norbert TARUS e.U., as President of the Board of Administrators, for signing all the documents issued following the Ordinary General Meeting of Shareholders.
Bucharest, April 25th 2024
Preşedinte al Consiliului de Administraţie,
"TARUS" - Valentin Norbert TARUS e.U.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Farmaceutica REMEDIA SA published this content on 25 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 April 2024 15:34:02 UTC.